Bactiguard today announced a PW driven by a one-time EBITDA effect of SEK -42m for Q2/23 from accrual of accounts receivable overdue (70%), write-down of inventories (15%), as well as costs related to other structural changes (15%). An in-depth review of financial items negatively affecting its business has been made. We are yet to publish a Q2 preview and currently expect SEK -6m in adj. EBITDA FY 2023E. The 2026 financial goals were reiterated in conjunction with the news.

https://research.sebgroup.com/corporate/reports/121441

SEB Research

This research has been commissioned by the company. Only for professional investors resident in EEA member states. Reports may not be distributed to the US or other jurisdictions where to do so would be unlawful. Please see the disclaimer tab for any details of investment banking services recently provided by SEB that could be considered relevant to the subject matter of this research.